Taken together, our data suggest a mixed tumor-associated immune response characterized by PD-L1 driven immune suppression by myeloid cells combined with pro- and anti-tumor CD8+ T-cell responses in the tumors of Pik3cg−/− mice. Here, CD8A is linked to neoplasm.